The Economist

The plan to rescue Denmark’s weight-loss pioneer

For more than two years it had the entirety of the market for weight-loss drugs to itself. By 2023 sales of Wegovy had ...

A Stumble for a Former Star: Novo Nordisk's Challenging Year

The coming year, 2026, is shaping up as a critical operational and financial test. A head-to-head comparative study between Novo Nordisk's CagriSema and Eli Lilly's Zepbound, scheduled for 2026, will ...

8 FDA-approved weight loss drugs: What are they & what are their side effects?

FDA-approved weight loss medications include injections (Wegovy®, Zepbound®, etc.) and pills, like Qsymia® and Xenical®. Most ...

Hims and Hers to offer weight-loss treatments in UK

Online telehealth company Hims and Hers Health is launching its weight-loss membership and treatment plans in the United ...

Hims and Hers to start weight-loss jab subscription in UK

Online telehealth company Hims and Hers Health HIMS.N is launching its weight-loss membership and treatment plans in the UK ...